First, the blockade of IL-1 improves glycemia and β-cell secretory function; repression of the IL-6 receptor relieves diabetic renal injury and insulin resistance, and suppression of GATA-3 restores insulin sensitivity (129, 143, 169). Here, IL1B is linked to Insulin resistance.